Projects per year
Personal profile
Area of Expertise
His interests focus on chemistry-driven multidisciplinary research and include the discovery, chemical biology, bioorganic, and medicinal chemistry of central nervous system agents, as well as neuropeptides, proteomics, and mass spectrometry.
Dr. Prokai has maintained an actively funded research program from grant support by the National Institutes of Health (NIH) as well as through collaborations with pharmaceutical and chemical companies. Dr. Prokai was the recipient of the 2017 Wilfred T. Doherty Award of the Dallas/Fort Worth Section of the American Chemical Society (ACS) and the 2017 Southwest ACS Regional Award.
Education/Academic qualification
MS in Chemistry, University of Veszprem
BS in Chemical Engineering, University of Veszprem
PhD in Radiochemistry, University of Veszprem
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
A Novel Neuroprotective Approa
Prokai-Tatrai, K. (PI), Sumien, N. (CoI) & Prokai, L. (CoI)
1/02/23 → 31/01/28
Project: Research
-
-
Brain-Selective Estrogen Thera
Prokai, L. (PI)
University of Maryland, Baltimore
15/01/21 → 31/12/25
Project: Research
-
Impact of Brain Estrogens on C
Prokai, L. (PI)
University of Massachusetts Amherst
1/01/21 → 31/12/25
Project: Research
-
Brain-selective estrogen therapy for menopausal hot flushes in an advanced translational animal model
PUCHE, A. (CoPI), Merchenthaler, I. (PI), PUCHE, A. (CoPI), Prókai, L. (CoPI), MERCHENTHALER, I. J. (CoPI), Prokai, L. (CoPI) & Prokai, L. (CoPI)
15/01/21 → 31/12/24
Project: Research
-
Neuropharmacodynamic evaluation of the centrally active thyrotropin-releasing hormone analogue [Leu2]TRH and its chemical brain-targeting system
Prokai, L. & Zharikova, A. D., 18 Oct 2002, In: Brain Research. 952, 2, p. 268-274 7 p.Research output: Contribution to journal › Article › peer-review
-
Ocular-specific chemical delivery systems of betaxolol for safe local treatment of glaucoma
Farag, H. H., Wu, W. M., Barros, M. D. C., Somogyi, G., Prokai, L. & Bodor, N., 1997, In: Drug Design and Discovery. 15, 2, p. 117-130 14 p.Research output: Contribution to journal › Article › peer-review
-
Microcolumn size-exclusion chromatography coupled with electrospray ionization mass spectrometry
Prokai, L., Aaserud, D. J. & Simonsick, W. J., 12 Mar 1999, In: Journal of Chromatography A. 835, 1-2, p. 121-126 6 p.Research output: Contribution to journal › Article › peer-review
-
Prodrugs of thyrotropin-releasing hormone and related peptides as central nervous system agents
Prokai-Tatrai, K. & Prokai, L., Feb 2009, In: Molecules. 14, 2, p. 633-654 22 p.Research output: Contribution to journal › Review article › peer-review
-
Synthesis and antibacterial activity of fused Mannich ketones
Lóránd, T., Kocsis, B., Sohár, P., Nagy, G., József, P., Kispál, G., László, R. & Prókai, L., Oct 2002, In: European Journal of Medicinal Chemistry. 37, 10, p. 803-812 10 p.Research output: Contribution to journal › Article › peer-review